IP Verse

Methods For Treating Hepcidin Mediated Disorders - EP3329018

PATENT ANALYSIS

Patent Details

Grant Date: Mar 31, 2021
Company: ASTRAZENECA PHARMACEUTICALS, LP
Oppositions

More patents of Astrazeneca Pharmaceuticals, Lp

Want to monitor this patent?

Feel free to send us a message here and we will get back to you